491 related articles for article (PubMed ID: 20813528)
1. Novel dihydropyrimidines as a potential new class of antitubercular agents.
Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents.
Bacelar AH; Carvalho MA; Proença MF
Eur J Med Chem; 2010 Jul; 45(7):3234-9. PubMed ID: 20416983
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of some novel 1,4-dihydropyridines as potential antitubercular agents.
Trivedi A; Dodiya D; Dholariya B; Kataria V; Bhuva V; Shah V
Chem Biol Drug Des; 2011 Nov; 78(5):881-6. PubMed ID: 21895982
[TBL] [Abstract][Full Text] [Related]
4. A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents.
Agarwal A; Srivastava K; Puri SK; Sinha S; Chauhan PM
Bioorg Med Chem Lett; 2005 Dec; 15(23):5218-21. PubMed ID: 16171994
[TBL] [Abstract][Full Text] [Related]
5. 1,5-Diaryl-2-ethyl pyrrole derivatives as antimycobacterial agents: design, synthesis, and microbiological evaluation.
Biava M; Porretta GC; Poce G; De Logu A; Meleddu R; De Rossi E; Manetti F; Botta M
Eur J Med Chem; 2009 Nov; 44(11):4734-8. PubMed ID: 19595488
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel antitubercular 1,5-dimethyl-2-phenyl-4-([5-(arylamino)-1,3,4-oxadiazol-2-yl]methylamino)-1,2-dihydro-3H-pyrazol-3-one analogues.
Ahsan MJ; Samy JG; Jain CB; Dutt KR; Khalilullah H; Nomani MS
Bioorg Med Chem Lett; 2012 Jan; 22(2):969-72. PubMed ID: 22197387
[TBL] [Abstract][Full Text] [Related]
7. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
Abdel-Rahman HM; El-Koussi NA; Hassan HY
Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro antimycobacterial activity of N1-nicotinoyl-3-(4'-hydroxy-3'-methyl phenyl)-5-[(sub)phenyl]-2-pyrazolines.
Shaharyar M; Siddiqui AA; Ali MA; Sriram D; Yogeeswari P
Bioorg Med Chem Lett; 2006 Aug; 16(15):3947-9. PubMed ID: 16725324
[TBL] [Abstract][Full Text] [Related]
9. 5-Nitro-2,6-dioxohexahydro-4-pyrimidinecarboxamides: synthesis, in vitro antimycobacterial activity, cytotoxicity, and isocitrate lyase inhibition studies.
Sriram D; Yogeeswari P; Senthilkumar P; Naidu G; Bhat P
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):765-72. PubMed ID: 20569083
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
11. Antimycobacterial activities of novel 1-(cyclopropyl/tert-butyl/4-fluorophenyl)-1,4-dihydro- 6-nitro-4-oxo-7-(substituted secondary amino)-1,8-naphthyridine-3-carboxylic acid.
Sriram D; Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V
J Med Chem; 2007 Nov; 50(24):6232-9. PubMed ID: 17960928
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
Jaso A; Zarranz B; Aldana I; Monge A
J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents.
Ali MA; Yar MS
Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863
[TBL] [Abstract][Full Text] [Related]
14. Antitubercular activities of novel benzothiazolo naphthyridone carboxylic acid derivatives endowed with high activity toward multi-drug resistant tuberculosis.
Dinakaran M; Senthilkumar P; Yogeeswari P; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):11-8. PubMed ID: 18078735
[TBL] [Abstract][Full Text] [Related]
15. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
[TBL] [Abstract][Full Text] [Related]
16. Facile one-pot synthesis and antimycobacterial evaluation of pyrazolo[3,4-d]pyrimidines.
Trivedi A; Dodiya D; Surani J; Jarsania S; Mathukiya H; Ravat N; Shah V
Arch Pharm (Weinheim); 2008 Jul; 341(7):435-9. PubMed ID: 18574851
[TBL] [Abstract][Full Text] [Related]
17. Microwave assisted one-pot synthesis of highly potent novel isoniazid analogues.
Manjashetty TH; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2011 Apr; 21(7):2125-8. PubMed ID: 21320779
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and optimization of antitubercular activities in a series of 4-(aryloxy)phenyl cyclopropyl methanols.
Bisht SS; Dwivedi N; Chaturvedi V; Anand N; Misra M; Sharma R; Kumar B; Dwivedi R; Singh S; Sinha SK; Gupta V; Mishra PR; Dwivedi AK; Tripathi RP
Eur J Med Chem; 2010 Dec; 45(12):5965-78. PubMed ID: 20970222
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro anticancer and antitubercular activity of diarylpyrazole ligated dihydropyrimidines possessing lipophilic carbamoyl group.
Yadlapalli RK; Chourasia OP; Vemuri K; Sritharan M; Perali RS
Bioorg Med Chem Lett; 2012 Apr; 22(8):2708-11. PubMed ID: 22437116
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel antitubercular 2,10-dihydro-4aH-chromeno[3,2-c]pyridin-3-yl derivatives.
Sriram D; Yogeeswari P; Dinakaran M; Banerjee D; Bhat P; Gadhwal S
Eur J Med Chem; 2010 Jan; 45(1):120-3. PubMed ID: 19942326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
